期刊
CANCER CONTROL
卷 27, 期 3, 页码 -出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/1073274820948047
关键词
biliary tract cancer; cholangiocarcinoma; immunotherapy; nivolumab; pd-l1; pembrolizumab; liver cancer; intrahepatic cholangiocarcinoma
类别
Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据